TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $24,180 | -0.1% | 571,100 | -1.4% | 0.04% | +2.7% |
Q4 2023 | $24,207 | +9.0% | 579,400 | -1.6% | 0.04% | -2.6% |
Q3 2023 | $22,204 | -1.6% | 588,800 | -1.0% | 0.04% | +15.2% |
Q2 2023 | $22,565 | +54.8% | 594,900 | -0.8% | 0.03% | +73.7% |
Q1 2023 | $14,577 | -18.0% | 599,400 | -2.0% | 0.02% | -20.8% |
Q4 2022 | $17,767 | -99.9% | 611,800 | -5.4% | 0.02% | -11.1% |
Q3 2022 | $19,394,000 | -21.6% | 646,900 | -5.5% | 0.03% | -6.9% |
Q2 2022 | $24,744,000 | -15.7% | 684,300 | +0.9% | 0.03% | -14.7% |
Q1 2022 | $29,343,000 | -15.9% | 678,300 | -2.5% | 0.03% | -20.9% |
Q4 2021 | $34,877,000 | -23.9% | 696,000 | -3.4% | 0.04% | -27.1% |
Q3 2021 | $45,845,000 | -13.6% | 720,500 | -2.3% | 0.06% | -10.6% |
Q2 2021 | $53,063,000 | -4.5% | 737,400 | -2.1% | 0.07% | -4.3% |
Q1 2021 | $55,541,000 | -3.6% | 753,100 | -4.1% | 0.07% | +9.5% |
Q4 2020 | $57,642,000 | +36.7% | 785,100 | +2.1% | 0.06% | +50.0% |
Q3 2020 | $42,158,000 | -13.6% | 768,600 | +4.8% | 0.04% | 0.0% |
Q2 2020 | $48,777,000 | +19.7% | 733,600 | +10.2% | 0.04% | +5.0% |
Q1 2020 | $40,759,000 | -24.8% | 666,000 | +8.0% | 0.04% | -4.8% |
Q4 2019 | $54,200,000 | +23.5% | 616,400 | +6.0% | 0.04% | +13.5% |
Q3 2019 | $43,889,000 | -7.1% | 581,700 | +5.2% | 0.04% | -11.9% |
Q2 2019 | $47,234,000 | +2.4% | 552,964 | +29.6% | 0.04% | 0.0% |
Q1 2019 | $46,133,000 | +43.3% | 426,800 | +12.2% | 0.04% | +20.0% |
Q4 2018 | $32,189,000 | -1.1% | 380,300 | +14.9% | 0.04% | +6.1% |
Q3 2018 | $32,537,000 | -44.9% | 331,000 | -39.6% | 0.03% | +3.1% |
Q2 2018 | $59,014,000 | +128.6% | 548,400 | +109.8% | 0.03% | +14.3% |
Q1 2018 | $25,811,000 | -2.5% | 261,400 | +3.4% | 0.03% | -3.4% |
Q4 2017 | $26,460,000 | -11.5% | 252,700 | -4.7% | 0.03% | -17.1% |
Q3 2017 | $29,897,000 | -1.5% | 265,300 | -2.0% | 0.04% | -10.3% |
Q2 2017 | $30,342,000 | -15.0% | 270,766 | -11.6% | 0.04% | -22.0% |
Q1 2017 | $35,709,000 | -38.1% | 306,200 | -44.1% | 0.05% | -45.1% |
Q4 2016 | $57,646,000 | -17.2% | 547,600 | -13.1% | 0.09% | -26.0% |
Q3 2016 | $69,610,000 | -23.0% | 629,900 | +1.4% | 0.12% | -28.5% |
Q2 2016 | $90,403,000 | +28.5% | 620,900 | +26.4% | 0.17% | +28.4% |
Q1 2016 | $70,379,000 | +0.9% | 491,300 | +8.9% | 0.13% | -11.8% |
Q4 2015 | $69,733,000 | +14.7% | 451,200 | +6.0% | 0.15% | +4.8% |
Q3 2015 | $60,814,000 | +1.6% | 425,600 | +2.2% | 0.14% | +6.6% |
Q2 2015 | $59,861,000 | +3.9% | 416,600 | +2.0% | 0.14% | +10.6% |
Q1 2015 | $57,626,000 | -3.6% | 408,606 | +1.3% | 0.12% | -14.6% |
Q4 2014 | $59,795,000 | -2.1% | 403,500 | +1.6% | 0.14% | -13.8% |
Q3 2014 | $61,099,000 | +17.4% | 397,110 | +7.0% | 0.17% | +38.0% |
Q2 2014 | $52,057,000 | +74.7% | 371,200 | +38.3% | 0.12% | +70.4% |
Q1 2014 | $29,792,000 | +27.9% | 268,400 | +14.0% | 0.07% | +26.8% |
Q4 2013 | $23,288,000 | +43.8% | 235,473 | +10.5% | 0.06% | +43.6% |
Q3 2013 | $16,196,000 | +77.5% | 213,100 | +30.6% | 0.04% | +62.5% |
Q2 2013 | $9,123,000 | – | 163,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 650,089 | $27,954 | 12.84% |
Analyst IMS Investment Management Services Ltd. | 13,557 | $583 | 0.02% |
LRI Investments, LLC | 2,000 | $85,778 | 0.01% |
Gladius Capital Management LP | 761 | $32,701 | 0.00% |
RHUMBLINE ADVISERS | 12,625 | $542,490 | 0.00% |
Lindbrook Capital, LLC | 142 | $6,102 | 0.00% |
Covestor Ltd | 26 | $1 | 0.00% |
Red Tortoise LLC | 40 | $1,719 | 0.00% |
OSAIC HOLDINGS, INC. | 199 | $8,551 | 0.00% |
Parallel Advisors, LLC | 19 | $816 | 0.00% |